By assaying the autoantibodies in sera of SLE patients, they revealed elevated levels of autoantibodies targeting several serum factors in SLE, including BAFF, TGF-β1, IL-2, IL-23, TNF, and IFN-α. This evidence concerns the gene TNFSF13B and systemic lupus erythematosus.